Rapiddx Technologies Pvt. Ltd.
A young multidisciplinary company founded in Bangalore, India.
We are working in the field of Anti-Microbial Resistance (AMR).
To provide high-quality affordable healthcare solutions to combat AMR.
We are developing a rapid Antimicrobial susceptibility test (AST) platform to reduce the time gap between sample collection and susceptibility detection. Our vision is to provide high-quality affordable healthcare solutions to combat AMR.
We employ Mechatronics, Microfluidics, and data analytics to provide cutting-edge solutions to AMR’s quest.
We use mechanical, electronics, & embedded programming skills to prioritize system-based thinking & interdisciplinary problem-solving.
Our self-reliant Microfluidics chip offers a number of advantages over conventional macroscale analytics like smaller reagent volume requirement, greater flexibility & affordability. Ease of use & low production cost makes it attractive to hospital and pathology work.
Increase your work efficiency and improve performance by discovering patterns in data.
Rapiddx Technologies selected for the AIT 2021 supported by Swissnex in India and Consulate general of Switzerland. The digital version of AIT India aims to transform high-level applied research into market applications.
Our platform uses patented sensor technology to test susceptibility directly from a clinical sample on a microfluidics platform. Patients, pathology staff, and hospitals are three main stakeholders who get directly benefited.